TURPxit or not: contemporary management options for benign prostatic obstruction
- PMID: 34283282
- PMCID: PMC8332635
- DOI: 10.1007/s00345-021-03780-9
TURPxit or not: contemporary management options for benign prostatic obstruction
References
-
- Bachmann A, Tubaro A, Barber N, d'Ancona F, Muir G, Witzsch U, Grimm M-O, Benejam J, Stolzenburg J-U, Riddick A, Pahernik S, Roelink H, Ameye F, Saussine C, Bruyère F, Loidl W, Larner T, Gogoi N-K, Hindley R, Muschter R, Thorpe A, Shrotri N, Graham S, Hamann M, Miller K, Schostak M, Capitán C, Helmut Knispel J, Thomas A. A European multicenter randomized noninferiority trial comparing 180 W GreenLight XPS laser vaporization and transurethral resection of the prostate for the treatment of benign prostatic obstruction: 12 month results of the GOLIATH study. J Urol. 2015 doi: 10.1016/j.juro.2014.09.001. - DOI - PubMed
-
- Kasivisvanathan V, Hussain M. Aquablation versus transurethral resection of the prostate: 1 year United States—cohort outcomes. Can J Urol. 2018;25(3):9317–9322. - PubMed
-
- Te AE, Malloy TR, Stein BS, Ulchaker JC, Nseyo UO, Hai MA. Impact of prostate-specific antigen level and prostate volume as predictors of efficacy in photoselective vaporization prostatectomy: analysis and results of an ongoing prospective multicentre study at 3 years. BJU Int. 2006;97(6):1229–1233. doi: 10.1111/j.1464-410X.2006.06197.x. - DOI - PubMed
-
- Speakman MJ, Cornu JN, Gacci M, Gratzke C, Mamoulakis C, Herrmann TRW, Omar MI, Rieken M, Tikkinen KAO, Gravas S. What Is the required certainty of evidence for the implementation of novel techniques for the treatment of benign prostatic obstruction? Eur Urol Focus. 2019;5(3):351–356. doi: 10.1016/j.euf.2019.05.014. - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical